Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Weekly Roundup: FICO Jumps, Carnival Slides, Pfizer Soars

2:13
 
Share
 

Manage episode 510525777 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

On this episode of Stock Movers, we take a look at some of this past week's biggest gainers and decliners:

- Fair Isaac (FICO) surged after the credit scoring company unveiled new pricing models that will allow mortgage lenders to calculate and distribute FICO Scores directly to borrowers. Lenders currently rely on the three nationwide credit bureaus, TransUnion, Equifax and Experian, to provide FICO scores. Under Fair Isaac's new offerings, lenders can choose to avoid credit bureaus' markup fees, though they would pay Fair Isaac $33 per borrower per score when a FICO-scored loan is closed.

- Carnival (CCL) shares slumped this week following the release of third-quarter earnings. The cruise line's net yields guidance for the fourth quarter trailed some expectations, and comments on cost headwinds in 2026. Still, analysts defended the stock, and see opportunities to offset cost pressures. Shares had been up 23% this year heading into Monday's print.

- Pfizer (PFE) helped lead pharmaceutical stocks to their best week in 23 years as a drug-pricing and tariff deal with the US government helped ease an overhang that’s been weighing on the sector for most of the year. Pfizer spurred the group’s advance on Tuesday when it agreed to slash some of its drug prices for Americans enrolled in the Medicaid insurance program in exchange for a three-year reprieve on import tariffs. The New York-based company also agreed to invest $70 billion in the US as part of an agreement with President Donald Trump.

See omnystudio.com/listener for privacy information.

  continue reading

980 episodes

Artwork
iconShare
 
Manage episode 510525777 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

On this episode of Stock Movers, we take a look at some of this past week's biggest gainers and decliners:

- Fair Isaac (FICO) surged after the credit scoring company unveiled new pricing models that will allow mortgage lenders to calculate and distribute FICO Scores directly to borrowers. Lenders currently rely on the three nationwide credit bureaus, TransUnion, Equifax and Experian, to provide FICO scores. Under Fair Isaac's new offerings, lenders can choose to avoid credit bureaus' markup fees, though they would pay Fair Isaac $33 per borrower per score when a FICO-scored loan is closed.

- Carnival (CCL) shares slumped this week following the release of third-quarter earnings. The cruise line's net yields guidance for the fourth quarter trailed some expectations, and comments on cost headwinds in 2026. Still, analysts defended the stock, and see opportunities to offset cost pressures. Shares had been up 23% this year heading into Monday's print.

- Pfizer (PFE) helped lead pharmaceutical stocks to their best week in 23 years as a drug-pricing and tariff deal with the US government helped ease an overhang that’s been weighing on the sector for most of the year. Pfizer spurred the group’s advance on Tuesday when it agreed to slash some of its drug prices for Americans enrolled in the Medicaid insurance program in exchange for a three-year reprieve on import tariffs. The New York-based company also agreed to invest $70 billion in the US as part of an agreement with President Donald Trump.

See omnystudio.com/listener for privacy information.

  continue reading

980 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play